Clozapine treatment in Australia: A review of haematological monitoring

Medical Journal of Australia

Volumn 168, Issue 10, 1998, Pages 495-497

  Copolov, David L ^a   Bell, William R ^a   Benson, Warwick J ^c   Keks, Nicholas A ^b   Strazzeri, Diane C ^a   Johnson, Gordon F ^d,e  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE;

ADULT; AGRANULOCYTOSIS; ARTICLE; AUSTRALIA; DATA BASE; DRUG MONITORING; FEMALE; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; SCHIZOPHRENIA;

EID: 0032543087     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb141414.x     Document Type: Article

References (10)

1. Amster HA, Teerenhoui L, Borth E, et al. Agranulocytosis in patients treated with clozapine: a study of the Finnish epidemic. Acta Psychiatr Scand 1977; 56: 241-248.
2. Deiter N, Hippius H. The European experience with use of clozapine. Hosp Commun Psychiatr 1990; 41: 886-890.
3. Kane J, Honigfield G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic - a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789-796.
4. Sandoz Australia (now Novartis Australia). Clozaril Patient Monitoring System Protocol. Sydney: Sandoz, 1995.
5. Chatterton R. Clozaril - an Australian experience. J Psychosoc Nurs Ment Health Serv 1995; 33: 24-27.
6. Alvir J, Ma J, Lieberman JA, Safferman AZ. Do white-cell count spikes predict agranulocytosis in clozapine recipients? Psychopharmacol Bull 1995; 31: 311-314.
7. Atkin K, Kendall F, Gould D, et al. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 1996; 169: 483-488.
8. Alvir J, Ma J, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med 1993; 329: 162-167.
9. Miller PR, Cutten AEC. Haematological side effects of clozapine: patient characteristics. N Z Med J 1997; 110: 125-127.
10. Krupp P, Barnes P. Clozapine-associated agranulocytosis: risk and aetiology. Br J Psychiatry 1992; 160 (Suppl 17): 38-40.